ELKAR solution 30% 50ml

Nosological classification (ICD-10)

E05.9 Thyrotoxicosis, unspecified
E34.3 Short stature [dwarfism], not elsewhere classified
E61.8 Insufficiency of other specified nutrients
E63 Physical and mental overload
F50.0 Anorexia nervosa
G24.8.1* Muscular hypotonia
G71.3 Mitochondrial myopathy, not elsewhere classified
G72.9 Myopathy, unspecified
G92 Toxic encephalopathy
I42 Cardiomyopathy
I67.9 Cerebrovascular disease, unspecified
K29.5 Chronic gastritis, unspecified
K29.6.0* Gastritis anacid
K86.1 Other chronic pancreatitis
L21 Seborrheic dermatitis
L40.9 Psoriasis, unspecified
L93.0 Discoid lupus erythematosus
L94.0 Localized scleroderma [morphea]
P07.0 Extremely low birth weight
P15.9 Birth injury, unspecified
P21 Birth asphyxia
P92.2 Sluggish sucking of the newborn
P94 Muscle tone disorders in the newborn
R41.8.0* Intellectual-mnestic disorders
R53 Malaise and fatigue
R54 Old age
R63.0 Anorexia
R63.4 Abnormal weight loss
T90 Consequences of head injuries
Z54.0 Convalescent period after surgery
Z54.4 Convalescence period after treatment of a fracture
Z54.8 Convalescent period after other treatment
Z73.0 Overfatigue
Z73.2 Lack of rest and relaxation
Z73.6 Restrictions in activity caused by decreased ability to work

Contraindications, indications for Elkar therapy

The instructions for the medication contain the following recommendations for the use of the drug as part of systemic treatment:

to increase performance indicators, reduce fatigue in stressful situations and heavy physical activity;
activation of regeneration processes after medical procedures, injuries, illnesses;
chronic forms of gastroduodenitis, pancreatitis - with decreased secretion production;
dermatological pathologies, including psoriasis, disseborrheic dermatitis, chronic connective tissue lesions, DLE;
mild forms of hyperthyroidism, eating disorders;
suppression of symptoms of neurological pathologies associated with intoxication, trauma, vascular diseases;
replenishment of carnitine deficiency.

For children under 3 years of age, Elkar is prescribed:

after oxygen starvation or fetal injury during labor;
with slow weight gain, weakness of the sucking reflex;
decreased muscle tone;
delayed development and growth up to the age of sixteen.

During intense training, the medication improves speed, strength, and coordination of movements. Can be used to accelerate recovery after heavy physical activity.

Effervescent granules of Elkar are prescribed for similar indicators. The medicine is contraindicated for use in patients with individual intolerance to the component composition. For the granular form, the limitation is the patient’s minor age.

Directions for use and doses

The drug is used as part of complex therapy.

Orally, 30 minutes before meals, further diluting with liquid.

For prolonged physical and psycho-emotional stress: from 0.75 g (1/2 measuring spoon or 2.5 ml) 3 times a day to 2.25 g (1.5 measuring spoon or 7.5 ml) 2-3 times a day day.

For anorexia nervosa, as well as during the rehabilitation period after illnesses and surgical interventions and injuries: 1.5 g (1 scoop or 5 ml) 2 times a day. The course of treatment is for 1–2 months.

In the complex therapy of chronic gastritis and chronic pancreatitis with reduced secretory function: 0.375 g (1/4 scoop or 1.25 ml) 2 times a day. The course of treatment is for 1–1.5 months.

For the treatment of skin diseases: 0.75 g (1/2 scoop or 2.5 ml). The course of treatment is for 2–4 weeks.

For mild hyperthyroidism: 0.25 g (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break or prescribed for 3 months without a break.

For vascular, toxic and traumatic brain lesions: 0.75 g (1/2 scoop or 2.5 ml) per day. The course of treatment is for 3–5 days. If necessary, a repeat course is prescribed after 12–14 days.

For diseases accompanied by a lack of carnitine (primary and secondary carnitine deficiency): up to 50–100 mg/kg (2–5 drops/kg) with a dosage frequency of 2–3 times a day. The course of treatment is for 3–4 months.

Children are prescribed as an additive to sweet dishes (jelly, compote, juice). For children under 3 years of age, the dose is determined by the attending physician. From 3 to 6 years - in a single dose of 0.1 g (5 drops) 2-3 times a day, in a daily dose of 0.2-0.3 g (11-16 drops). The course of treatment is 1 month. Children from 6 to 12 years old - in a single dose of 0.2–0.3 g (11–16 drops) 2–3 times a day, in a daily dose of 0.4–0.9 g (22–48 drops). The course of treatment is at least 1 month.

For growth retardation: 0.25 g (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break or prescribed for 3 months without a break.

In sports medicine and during intense training: 2.5 g 1–3 times a day (daily dose 2.5–7.5 g); in case of use for therapeutic purposes - 70–100 mg/kg/day (5–7.5 g/day). The course of admission is 3–4 weeks in the pre-competition period. During the training process - up to 6–8 weeks.

Elkar - a drug based on L-carnitine

Amino acids and vitamin-like substances are activators of a wide variety of biological processes. One of these amino acids is L-carnitine (levocarnitine), which is structurally reminiscent of B vitamins.

Despite the fact that this amino acid is synthesized in the body, there are a number of diseases and developmental abnormalities in which there is a deficiency. In order to replenish the existing deficiency, the drug Elkar was synthesized.

Elkar-20, 30% is a universal corrector and stimulator of energy metabolism, which improves the activity of the nervous system and brain structures in general; promotes recovery of the body after operations and diseases; improves the condition of organs and systems of the body; supports the ability to withstand high loads. Elkar-20, 30% belongs to the group of drugs containing levocarnitine, which takes an active part in metabolism and the formation of human energy potential.

Elkar-20, 30% increases enzymatic activity and secretion of gastrointestinal juices, thereby improving food absorption.

Elcar is an analogue of L-carnitine, a carrier of fatty acids through cell membranes into mitochondria from the cytoplasm, where β-oxidative processes subsequently occur with the formation of ATP and acetyl-CoA.

Release form

The drug is available in bottles (25/50/100 ml) in the form of a colorless, transparent or lightly colored solution of various concentrations - 20 and 30% (Elkar 20 and Elkar 30 percent). A specific odor may be present when opening the bottle. Also available as a solution in ampoules of 5 ml and Elkar tablets (in the form of chewable tablets).

Elkar - composition and indications for use

The drug Elkar has the following composition:

the main active ingredient is levocarnitine;
excipients - methyl parahydroxybenzoate, propyl parahydroxybenzoate, citric acid monohydrate, purified water.

Indications for use of the drug Elkar - 20, 30%:

As a rule, it is part of complex therapy for the following conditions:

intense psycho-emotional and physical stress, increased fatigue, reduced performance and endurance (especially in the elderly);
during the period of rehabilitation after illnesses and surgical interventions;
in the complex treatment of diseases of the gastrointestinal tract, skin diseases, mild hyperthyroidism, traumatic and neurological lesions of the brain, and with a lack of carnitine in the body.

The drug Elkar is widely prescribed to children. In pediatric practice, Elkar is indicated for children with a number of deviations from the norm in newborns. Elkar is prescribed to children under one year of age when caring for newborns with birth trauma, premature babies who have suffered asphyxia. Elkar is also prescribed to infants with insufficient development of mental and motor functions, with a sluggish sucking reflex, decreased muscle tone, and low weight gain. It is recommended to prescribe Elkar to children under one year of age and in order to prevent such disorders in children at risk. Elkar is recommended for children and older adults - children and adolescents under 16 years of age with underweight and stunted growth.

Elkar - application and dosage

The drug Elkar is used in the following dosages and methods:

1. For adults, Elkar is prescribed 30 minutes before meals, orally, diluted with additional liquid.

for thyrotoxicosis and growth retardation - 0.25 g 3 times a day for 20 days;
to increase appetite and weight gain for patients with chronic pancreatitis and gastritis - 0.5 g 2 times a day, for 1-1.5 months;
for prolonged high physical activity, a dose of 1-2 g is prescribed 2-3 times a day 30 minutes before meals.

2. Elkar for children, dosage:

Elkar is prescribed to infants (up to one year old) 3 times in a single dose of 10 drops (0.075 g) per day as an additive to juices, jelly, compotes);
Elkar for children under 2 years of age with genetic diseases and primary/secondary deficiency is prescribed in doses of 0.15 g/kg/day, for children aged 2 to 6 years – in a dose of 0.1 g/kg/day;
Elkar is prescribed to children 6-12 years old at a dose of 0.75 g/kg/day, and after 12 years to adults - at a dose of 2-4 g/kg/day.

Elkar is prescribed to children under 3 years of age under the supervision of a doctor. Elkar for children, the dosage can be prescribed individually depending on the age, disease and condition of the child.

Contraindications for use

Taking Elkar is contraindicated in the presence of individual intolerance (history of hypersensitivity) to the drug as a whole, or if the body is intolerant to taking individual components of Elkar. Due to the lack of reliable scientific research, the use of Elkar during pregnancy, as well as during breastfeeding unless absolutely necessary, is not recommended.

Elkar - side effects

When taking the drug Elkar, side effects are possible in the form of allergic reactions, as well as from the gastrointestinal tract: pain in the epigastric region, dyspepsia. If side effects are detected, taking Elcar should be discontinued or its dosage reduced.

elkar

Release form

Oral solution, 300 mg/ml.

Glass bottle, 100 ml. 100 ml in dark glass bottles, sealed with caps with a control ring for the first opening. A 20 ml measuring cup is placed on the bottle. Each bottle is placed in a cardboard pack.

Glass bottle, 50 ml. 50 ml in dark glass bottles, sealed with caps with droppers with a control ring for the first opening. Each bottle, together with a measuring spoon with a nominal volume of 5 ml with marks marked “1/4” and “1/2” (corresponding to 1.25 and 2.5 ml), is placed in a cardboard pack.

Glass bottle, 25 ml. 25 ml in dark glass bottles, sealed with caps with droppers with a control ring for the first opening. Each bottle is placed in a cardboard pack.

Adverse reactions

Non-standard clinical symptoms during Elkar therapy occur in rare cases. The instructions indicate the following manifestations:

in patients with uremia – weakness and fatigue of muscle tissue;
dyspepsia, pain in the pelvis and abdomen;
allergic dermatitis, skin rashes.

The appearance of side effects of Elkar requires consultation with a doctor and a change in the initial treatment regimen. Excessive use of the medication can cause dyspepsia and myasthenia gravis. Symptomatic therapy consists of gastric lavage and the use of activated carbon - 1 tablet per 10 kg of body weight.